By Ben Hirschler LONDON (Reuters) – GlaxoSmithKline will this week inform U.S.
staff of hundreds of job cuts in its biggest market as the drugmaker starts
implementing a major cost-saving program, sources familiar with the matter said
on Sunday.
Report: Drug Maker GSK To Slash U.S. Jobs, Part of $1.6 Billion in Cuts
